Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01878383 · ClinicalTrials.gov registry record
Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 12,550
- Enrollment target
NCT01878383: Completed study, sponsored by University of Alabama at Birmingham.
NCT01878383 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 12,550 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01878383 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 12,550 participants
- Enrollment target
Study Summary
PCR detection of HSV DNA shedding in the female genital tract using the GeneXpert system (Cepheid, Sunnyvale CA) will be compared with traditional (routine) PCR (pregnant and nonpregnant women) and with HSV culture (nonpregnant women). The GeneXpert system performs all sample-processing steps and real-time PCR in a single integrated cartridge. The standard cartridge is an inexpensive disposable plastic cartridge with filtration and ultrasonic lysis capabilities. It consists chiefly of several combined molded plastic components: a cartridge body containing eleven fluid reservoirs or chambers along with an attached PCR tube, a specialized valve body with an ultrasonic interface containing a sub-micron filter and glass lysis beads, and a rotary valve with an axial syringe barrel. The operation of the cartridge is simple. The rotary valve contains an inlet and an outlet port. Fluid such as a sample buffer can be drawn up into a syringe drive through the inlet port of the rotary valve and then dispensed into any other chamber within the cartridge by rotating the valve and expelling the fluid through the outlet port. The fluid can either be passed through a filter contained within the valve assembly or it can be passed directly into the next chamber without filtration, depending on the path that is chosen. The cartridge fluidics and subsequent real-time PCR all are performed within the GeneXpert instrument. The GeneXpert contains multiple modules (ICORE units) that can be independently programmed to drive the syringe/rotary valve, and to perform four-color real-time PCR. Each cartridge fits inside one module, and all processing, PCR, and analysis steps are performed automatically. Each ICORE module can be run and analyzed independently, so batching of samples is unnecessary.
Primary Outcome
Assessing the vaginal specimen collected via a swab of non-pregnant women presenting to their provider at the time of active HSV outbreak with standard HSV culture compared to the assay of new device called a GeneXpert. Percent of GeneXpert assessment in agreement with standard HSV culture, for subjects who were positive for HSV according to culture.
Interventions
- DEVICE Genexpert assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,550 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-12-31 |
What the finished NCT01878383 record still lists
NCT01878383 is an observational study that tracks outcomes without assigning an intervention. Its 12,550 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Genexpert assay is the first listed.
NCT01878383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01878383 about?
NCT01878383 is a clinical study titled "Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture". PCR detection of HSV DNA shedding in the female genital tract using the GeneXpert system (Cepheid, Sunnyvale CA) will be compared with traditional (routine) PCR (pregnant and nonpregnant women) and with HSV culture (nonpregnant women). The GeneXpert system performs all sample-processing steps and re...
What is the current status of trial NCT01878383?
This trial is currently completed. The enrollment target is 12,550 participants. The study started on 2014-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT01878383?
The interventions under investigation include: Genexpert assay (DEVICE).
Who is sponsoring clinical trial NCT01878383?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT07037433 · 12,800 participants · Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia